InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Traylor Margie L., Director. Officer active across 1 company, notably Augmedix, Inc.. In total, 5 disclosures have been logged. Split: 5 buys · 0 sell. Total volume traded: €25k. Activity tracked since 26 October 2021. The latest transaction was disclosed on 26 May 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations5 total
7,305 shares@ US$1.9854.3% of flowCommon StockSEC:0001213900-22-030197:0
Ideal exit: 20 Feb 2023 (T+270)
918 shares@ US$3.5311.6% of flowCommon StockSEC:0001213900-21-062382:0
Ideal exit: 23 Aug 2022 (T+270)
918 shares@ US$3.5350.9% of flowCommon StockSEC:0001213900-21-062382
Ideal exit: 23 Aug 2022 (T+270)
900 shares@ US$3.5911.2% of flowCommon StockSEC:0001213900-21-060408:0
Ideal exit: 23 Jul 2022 (T+270)
900 shares@ US$3.5949.1% of flowCommon StockSEC:0001213900-21-060408
Ideal exit: 23 Jul 2022 (T+270)
5 of 5 declarations
About Traylor Margie L.
Margie L. Traylor is a Board Member of Augmedix, Inc. In this role, she participates in the governance and strategy of the company. Her experience in the technology sector is valuable in guiding key decisions.
